Product Information
CARBIDOPA-LEVODOPA 10-100 TAB is a generic product labeled by ScieGen Pharmaceuticals Inc., priced at $0.0675 per EA under NDC 50228045701. Its NADAC has been published 260 times since Sep 1, 2021.
FDA first approved this application on May 7, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 100 mg/1; mg/1
Manufacturer
ScieGen Pharmaceuticals Inc.NDC
50228045701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CARBIDOPA; LEVODOPAApproval Type
Generic (ANDA)
FDA Application
ANDA214092FDA Approved
5/7/2021
TE Code
AB
On Market Since
5/7/2021
Pharmacological Classes
Price Statistics
The NADAC for CARBIDOPA-LEVODOPA 10-100 TAB has been published 260 times since Sep 1, 2021, and over the history we have for it it has declined 43.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0675 per EA |
|---|---|
| All-time high | $0.1599 (Mar 16, 2022) |
| All-time low | $0.0637 (Jul 22, 2026) |
| 52-week high | $0.0948 |
| 52-week low | $0.0637 |
| Median price | $0.1038 |
| Average price | $0.1098 |
| Largest weekly change | -28.9% (Apr 17, 2024) |
| Weeks tracked | 260 |
| Tracking since | Sep 1, 2021 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CARBIDOPA-LEVODOPA 10-100 TAB?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVODOPA 10-100 TAB, manufactured by ScieGen Pharmaceuticals Inc., is $0.0675 per EA (NDC 50228045701), effective Aug 19, 2026.
How has the price of CARBIDOPA-LEVODOPA 10-100 TAB changed over time?
Over the history we have for it, the NADAC for CARBIDOPA-LEVODOPA 10-100 TAB has declined 43.1%. It has been tracked across 260 weekly CMS publications since Sep 1, 2021.
What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVODOPA 10-100 TAB?
Since Sep 1, 2021, the NADAC for CARBIDOPA-LEVODOPA 10-100 TAB has ranged from a low of $0.0637 (Jul 22, 2026) to a high of $0.1599 (Mar 16, 2022), with a median of $0.1038 per EA.
Are there cheaper alternatives to CARBIDOPA-LEVODOPA 10-100 TAB?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CARBIDOPA-LEVODOPA 10-100 TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures CARBIDOPA-LEVODOPA 10-100 TAB?
CARBIDOPA-LEVODOPA 10-100 TAB (NDC 50228045701) is labeled by ScieGen Pharmaceuticals Inc., and CMS classifies it as a generic product.